Changes for page Neurodiagnoses
Last modified by manuelmenendez on 2025/03/03 22:46
From version 35.1
edited by manuelmenendez
on 2025/02/02 00:48
on 2025/02/02 00:48
Change comment:
There is no comment for this version
To version 32.1
edited by manuelmenendez
on 2025/01/29 19:12
on 2025/01/29 19:12
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -17,17 +17,10 @@ 17 17 18 18 = **Overview** = 19 19 20 +The classification and diagnosis of central nervous system (CNS) diseases have long been constrained by traditional phenotypic approaches that fail to capture the underlying pathophysiological mechanisms, molecular biomarkers, and neuroanatomical changes that drive disease progression. For instance, neurodegenerative and psychiatric disorders exhibit significant clinical overlap, co-pathology, and heterogeneity, a new diagnostic framework is urgently needed—one that shifts from symptom-based classifications toward an etiology-driven, tridimensional system integrating genetics, proteomics, neuroimaging, and computational modeling. By leveraging AI, multi-modal biomarkers, and precision medicine, this framework aims to provide a more objective, scalable, and biologically grounded approach to diagnosing and managing CNS diseases, ultimately leading to earlier detection, personalized interventions, and improved patient outcomes. 20 20 21 -The c lassificationand diagnosisof **central nervoussystem (CNS)diseases** havengbeenconstrainedby **traditionalphenotype-basedapproaches**,which oftenfailtocapture the**complex pathophysiological mechanisms, molecular biomarkers, and neuroanatomicalchanges** that drive diseaseprogression. **Neurodegenerative and psychiatricdisorders**,forexample, exhibitsignificant**clinicaloverlap,co-pathology,andheterogeneity**, making currentdiagnosticmodelsinsufficient.22 +The project aims to develop a tridimensional diagnostic framework with an AI-powered annotation system, integrating etiology, molecular biomarkers, and neuroanatomoclinical correlations for precise and scalable CNS disease diagnostics. 22 22 23 -This project proposes a **new diagnostic framework**—one that **shifts from symptom-based classifications** to an **etiology-driven, tridimensional system**. By integrating **genetics, proteomics, neuroimaging, computational modeling, and AI-powered annotations**, this approach aims to provide a **more precise, scalable, and biologically grounded method for diagnosing and managing CNS diseases**. 24 - 25 -The **AI-powered annotation system** plays a critical role by **structuring, interpreting, and tracking multi-modal data**, ensuring **real-time disease progression analysis, clinician decision support, and personalized treatment pathways**. 26 - 27 -=== **Project Aim** === 28 - 29 -The project aims to develop a **tridimensional diagnostic framework** with an **AI-powered annotation system**, integrating **etiology, molecular biomarkers, and neuroanatomoclinical correlations** for **precise, standardized, and scalable CNS disease diagnostics**. 30 - 31 31 The //Tridimensional Diagnostic Framework// redefines CNS diseases can be classified and diagnosed by focusing on: 32 32 33 33 * **Axis 1**: Etiology (genetic or other causes of diseases). ... ... @@ -40,16 +40,6 @@ 40 40 * Integration of incomplete datasets using AI-driven probabilistic modeling. 41 41 * Stratification of patients for personalized treatment. 42 42 43 -== **The Role of AI-Powered Annotation** == 44 - 45 -To enhance **standardization, interpretability, and clinical application**, the framework integrates **an AI-powered annotation system**, which: 46 - 47 -* **Assigns structured metadata tags** to diagnostic features. 48 -* **Provides real-time contextual explanations** for AI-based classifications. 49 -* **Tracks longitudinal disease progression** using timestamped AI annotations. 50 -* **Improves AI model transparency** through interpretability tools (e.g., SHAP analysis). 51 -* **Facilitates decision-making for clinicians** by linking annotations to standardized biomedical ontologies (SNOMED, HPO). 52 - 53 53 == **The case of neurodegenerative diseases** == 54 54 55 55 There have been described these 3 diagnostic axes: ... ... @@ -120,7 +120,6 @@ 120 120 * `/data`: Sample datasets for testing. 121 121 * `/outputs`: Generated models, visualizations, and reports. 122 122 * [[Methodology>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Methodology/]] 123 -* [[Notebooks>>Notebooks]] 124 124 * [[Results>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Results/]] 125 125 * [[to-do-list>>to-do-list]] 126 126 )))